Your browser doesn't support javascript.
SARS-CoV-2 infection and persistence in the human body and brain at autopsy.
Stein, Sydney R; Ramelli, Sabrina C; Grazioli, Alison; Chung, Joon-Yong; Singh, Manmeet; Yinda, Claude Kwe; Winkler, Clayton W; Sun, Junfeng; Dickey, James M; Ylaya, Kris; Ko, Sung Hee; Platt, Andrew P; Burbelo, Peter D; Quezado, Martha; Pittaluga, Stefania; Purcell, Madeleine; Munster, Vincent J; Belinky, Frida; Ramos-Benitez, Marcos J; Boritz, Eli A; Lach, Izabella A; Herr, Daniel L; Rabin, Joseph; Saharia, Kapil K; Madathil, Ronson J; Tabatabai, Ali; Soherwardi, Shahabuddin; McCurdy, Michael T; Peterson, Karin E; Cohen, Jeffrey I; de Wit, Emmie; Vannella, Kevin M; Hewitt, Stephen M; Kleiner, David E; Chertow, Daniel S.
  • Stein SR; Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  • Ramelli SC; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Grazioli A; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  • Chung JY; Kidney Disease Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Singh M; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Yinda CK; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institute of Health, Hamilton, MT, USA.
  • Winkler CW; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institute of Health, Hamilton, MT, USA.
  • Sun J; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institute of Health, Hamilton, MT, USA.
  • Dickey JM; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  • Ylaya K; Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  • Ko SH; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Platt AP; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Burbelo PD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Quezado M; Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  • Pittaluga S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Purcell M; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
  • Munster VJ; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Belinky F; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Ramos-Benitez MJ; University of Maryland School of Medicine, Baltimore, MD, USA.
  • Boritz EA; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institute of Health, Hamilton, MT, USA.
  • Lach IA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Herr DL; Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  • Rabin J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Saharia KK; Postdoctoral Research Associate Training Program, National Institute of General Medical Sciences, National Institutes of Health, Bethesda, MD, USA.
  • Madathil RJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Tabatabai A; Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  • Soherwardi S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • McCurdy MT; R Adams Cowley Shock Trauma Center, Department of Medicine and Program in Trauma, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Peterson KE; Department of Medicine, Division of Infectious Disease, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Cohen JI; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • de Wit E; Department of Surgery, Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Vannella KM; Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Hewitt SM; Hospitalist Department, TidalHealth Peninsula Regional, Salisbury, MD, USA.
  • Kleiner DE; Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Chertow DS; Division of Critical Care Medicine, Department of Medicine, University of Maryland St. Joseph Medical Center, Towson, MD, USA.
Nature ; 612(7941): 758-763, 2022 12.
Artículo en Inglés | MEDLINE | ID: covidwho-2160240
ABSTRACT
Coronavirus disease 2019 (COVID-19) is known to cause multi-organ dysfunction1-3 during acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with some patients experiencing prolonged symptoms, termed post-acute sequelae of SARS-CoV-2 (refs. 4,5). However, the burden of infection outside the respiratory tract and time to viral clearance are not well characterized, particularly in the brain3,6-14. Here we carried out complete autopsies on 44 patients who died with COVID-19, with extensive sampling of the central nervous system in 11 of these patients, to map and quantify the distribution, replication and cell-type specificity of SARS-CoV-2 across the human body, including the brain, from acute infection to more than seven months following symptom onset. We show that SARS-CoV-2 is widely distributed, predominantly among patients who died with severe COVID-19, and that virus replication is present in multiple respiratory and non-respiratory tissues, including the brain, early in infection. Further, we detected persistent SARS-CoV-2 RNA in multiple anatomic sites, including throughout the brain, as late as 230 days following symptom onset in one case. Despite extensive distribution of SARS-CoV-2 RNA throughout the body, we observed little evidence of inflammation or direct viral cytopathology outside the respiratory tract. Our data indicate that in some patients SARS-CoV-2 can cause systemic infection and persist in the body for months.
Asunto(s)

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Especificidad de Órganos / Autopsia / Encéfalo / SARS-CoV-2 / COVID-19 Tipo de estudio: Estudios diagnósticos Tópicos: Covid persistente Límite: Humanos Idioma: Inglés Revista: Nature Año: 2022 Tipo del documento: Artículo País de afiliación: S41586-022-05542-y

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Especificidad de Órganos / Autopsia / Encéfalo / SARS-CoV-2 / COVID-19 Tipo de estudio: Estudios diagnósticos Tópicos: Covid persistente Límite: Humanos Idioma: Inglés Revista: Nature Año: 2022 Tipo del documento: Artículo País de afiliación: S41586-022-05542-y